Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity.
Farhat-Younis L, Na M, Zarfin A, Khateeb A, Santana-Magal N, Richter A, Gutwillig A, Rasoulouniriana D, Gleiberman A, Beck L, Giger T, Ashkenazi A, Barzel A, Rider P, Carmi Y.
Farhat-Younis L, et al. Among authors: rider p.
Elife. 2024 Jun 17;12:RP91999. doi: 10.7554/eLife.91999.
Elife. 2024.
PMID: 38885133
Free PMC article.